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High Levels of Saturated Fatty Acids may
Exacerbate the Pathogenesis of Primary
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Abstract Obesity and type 2 diabetes (T2D) are characterized by decreased insulin
sensitivity and higher concentrations of free fatty acids (FFAs) in the serum.
Among FFAs, saturated fatty acids, such as palmitate, have been reported to play
a role in obesity-associated inflammation. Primary Sjo¨gren’s syndrome (SS) is an
autoimmune disease characterized by infiltration of inflammatory mononuclear
cells and destruction of epithelial cells in salivary and lacrimal glands. Although
epidemiological studies have suggested a link between primary SS and
dyslipidemia or T2D, little is known about the clinical significance of elevated
serum level of FFAs in primary SS. In salivary gland epithelial cells of patients with
primary SS, interleukin (IL)-6 production and α-fodrin degradation are increased.
IL-6 is one of the pro-inflammatory cytokines, and the cleavaged α-fodrin serves as
an auto-antigen. In this study, we demonstrate that palmitate, but not unsaturated
fatty acids, induces IL-6 production and α-fodrin degradation in human salivary
gland epithelial cell lines. However, palmitate did not induce these responses in
keratinocytes. Taken together, these results suggest that higher levels of saturated
fatty acids may promote the severity of primary SS.
Keywords Apoptosis • Interleukin-6 • Lipids • Palmitate • Sjo¨gren’s syndrome
• α-fodrin
Y. Shikama (*) • Y. Bando • N. Aki • M. Funaki
Clinical Research Center for Diabetes, Tokushima University Hospital, 2-50-1
Kuramoto-cho, Tokushima 770-8503, Japan
e-mail: shikama@tokushima-u.ac.jp
N. Ishimaru • Y. Kudo • R. Arakaki • Y. Hayashi
Department of Oral Molecular Pathology, Institute of Health Biosciences,
The University of Tokushima Graduate School, 3-18-15 Kuramoto-cho,
Tokushima 770-8504, Japan
© The Author(s) 2015




Obesity is rapidly prevailing and is one of the major threats to global health these
days. The epidemic of obesity has resulted in dramatic increases in the prevalence
of obesity-associated diseases including type 2 diabetes (T2D) [1]. It has been
known that the level of free fatty acids (FFAs) in the blood is elevated in T2D
patients as well as animal models of T2D [2], which is attributable to enhanced
lipolysis in adipocytes and increased consumption of dietary lipids [3]. It has been
demonstrated that saturated fatty acids (SFAs), such as palmitate and stearate,
induce inflammatory responses presumably activation of Toll-like receptor (TLR)
4 and its downstream signaling pathway [4–6]. TLRs are one of the pattern
recognition receptors that play a key role in induction of innate and adaptive
immune response through recognition of pathogen-associated molecular patterns
(PAMPs) of microbes [7]. Furthermore, excess amount of FFAs in the blood can
lead to proinflammatory response and intracellular lipid accumulation, which could
also result in cellular dysfunction, so-called ‘lipotoxicity’. Lipotoxicity has been
reported in pancreatic β cells, hepatocytes, cardiomyocytes, and skeletal muscle
cells [8], but hardly reported in epithelial cells such as epithelial cells in exocrine
glands.
Primary Sjo¨gren’s syndrome (SS) is an autoimmune disorder that is character-
ized by chronic dysfunction and destruction of exocrine glands, mainly the salivary
and lacrimal glands associated with chronic lymphocytic infiltrating lesions, that
leads to persistent dryness of eyes and mouth. Emerging evidence suggests that
salivary gland epithelial cells also actively participate in the inflammatory process
of SS [9]. For instance, interleukin (IL)-6, which is one of proinflammatory
cytokines known to serve as a B cell growth factor and a vital factor for plasma
cell survival [10], is upregulated in salivary gland epithelial cells of SS patients
[11–13]. IL-6 production is induced by activation of intracellular signaling cas-
cades including the mitogen-activated protein kinase (MAPK) pathways and the
nuclear factor-κB (NF-κB) pathway [14]. It has been also reported that α-fodrin,
which is a ubiquitously-expressed heterodimeric calmodulin-binding protein, is
cleaved during apoptosis by caspase-3 or μ-calpain to produce 120 kDa fragments
in salivary gland ductal epithelial cells. These α-fodrin-derived 120 kDa
fragments have been shown to serve as an auto-antigen in murine and human
primary SS [15, 16].
An association between obesity-related metabolic disorders and SS was first
reported in “pseudo-Sjo¨gren syndrome” [17, 18], which was followed by an
experimental study in mice that reported a link between SS and diabetes [19].
Moreover, it was recently reported that primary SS patients had significantly higher
incidence of metabolic disorders, such as T2D [20, 21]. These observations
described above led us to hypothesize that SFAs may induce IL-6 secretion,
lipotoxicity, and α-fodrin degradation in human salivary gland epithelial cells. In
this report, we provide evidence that SFAs, but not unsaturated fatty acids, induce
IL-6 secretion mediated by activation of p38 MAPK and NF-κB activation.
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Palmitate also induces intracellular lipid accumulation and apoptosis, and α-fodrin
degradation. However, these SFAs-dependent responses observed in salivary gland
epithelial cells are not common among epithelial cells in other type of tissues.
These observations implicate that salivary gland epithelial cells are susceptible to
palmitate-induced IL-6 secretion, lipotoxicity, and α-fodrin degradation, which
could exacerbate the pathogenesis of primary SS in salivary glands.
18.2 Materials and Methods
18.2.1 Reagents
Fetal bovine serum (FBS) and penicillin/streptomycin were purchased from Life
Technologies (Carlsbad, CA). Dulbecco’s modified Eagle’s medium (DMEM),
FFAs, SP600125, SB203580, and BAY11-7082 were obtained from Sigma-Aldrich
(St. Louis, MO). FFA-free bovine serum albumin (BSA) was obtained from Merck
(Darmstadt, Germany). A stock solution of FFA was prepared and conjugated with
BSA as described previously [22] with slight modifications as follows; FFA was
dissolved at a concentration of 100 mM in 0.1 mol/L NaOH at 90 C for 20 min,
which was then diluted 10-fold with 10 % BSA solution pre-incubated at 55 C. The
solution was vortexed for 10 s and incubated at 55 C for additional 10 min. FFA
solution of 10 mmol/L FFA with 10 % BSA and 10%BSA control solutions were
prepared just before experiments. FFA preparations were checked for LPS contam-
ination using Limulus Color KY Single Test (Wako).
18.2.2 Antibodies
Anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH), anti-IκBα,
antiphospho-IκBα (Ser32/36), anti-p38 MAPK, antiphospho-p38 MAPK (Thr180/
Tyr182), anti-SAPK/JNK, antiphospho-SAPK/JNK (Thr183/Tyr185), anti-
caspase-3, and anti-calpain1 (μ-type) antibodies were purchased from Cell Signal-
ing Technology (Danvers, MA). Anti-α-fodrin was obtained from Enzo Life Sci-
ences (Plymouth Meeting, PA).
18.2.3 Cells and Cell Culture
A human parotid gland ductal epithelial cell line HSY and a human submandibular
gland ductal epithelial cell line HSG were developed as described previously
[23, 24]. A human oral squamous carcinoma cell line HSC-2 was provided by
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Japanese Collection of Research Bioresources Cell Bank (Osaka, Japan). An
immortalized human keratinocyte cell line HaCaT was obtained from Dr. Norbert
E. Fusenig (German Cancer Research Center, Heidelberg, Germany). Cells were
cultured in DMEM supplemented with 10 % FBS, 100 U/mL penicillin and 100 μg/
mL streptomycin at 37 C with a humidified atmosphere of 5 % CO2. Cells were
serum starved (0.1 % BSA) overnight for experiments.
18.2.4 RNA Isolation and RT-PCR
Cells were lysed in 1 mL of ISOGEN (Nippon Gene, Tokyo, Japan), and total RNA
was extracted as described in the manufacturer’s instructions. One μg of total
RNA was reverse transcribed into cDNA with a first-strand cDNA synthesis
kit (Roche Diagnostics, Indianapolis, IN). Primers used were as follows:
TLR4 (forward) 50-TGGATACGTTTCCTTATAAG-30 and (reverse)
50-GAAATGGAGGCACCCCTTC-30; IL-6 (forward) 50-AAGCCAGAGCTGTG
CAGATGAGTA-30 and (reverse) 50-TGTCCT GCAGCCACTGGTTC-30;
GAPDH (forward) 50-GCCACATCGCTCAGACAC-30 and (reverse) 50-CTCGC
TCCTGGAAGATGG-30. PCR products were then subjected to agarose gel elec-
trophoresis and analyzed with an LAS-3000 UV Lumino-image analyzer (Fujifilm,
Tokyo, Japan).
18.2.5 Measurement of IL-6 Production
Cells were seeded into 96-well plates at a concentration of 1 105 cells/well
(Orange Scientific, Braine-l’Alleud, Belgium) and incubated overnight. After
treating the cells as described in the figure legends, the medium was collected.
The amount of IL-6 in the medium was determined using a human IL-6 ELISA kit
(Thermo Scientific, Rockford, IL) according to the manufacturer’s instructions.
18.2.6 Immunoblotting
After treating the cells as described in the figure legends, cells were rinsed three
times with ice-cold phosphate-buffered saline (PBS) and lysed in radio-
immunoprecipitation assay buffer [50 mM Tris, 150 mM NaCl, 1 % sodium
deoxycholate, 1 % Triton X-100, 0.1 % sodium dodecyl sulfate, 1 mM sodium
orthovanadate, and 1 % protease inhibitor cocktail (Sigma) (pH 7.5)]. Cell lysates
obtained by centrifugation at 15,000 g and 4 C for 10 min were subjected to
SDS-PAGE and transferred to polyvinylidene diflouride (PVDF) membranes as
described previously [25]. In some experiments, antibodies were diluted in Can Get
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Signal (Toyobo, Osaka, Japan). Immunoblotting was performed with an ECL PLUS
system according to the manufacturer’s instructions, and analyzed by a LAS-3000
UV Lumino-image analyzer (Fujifilm).
18.2.7 Oil Red O Staining
To evaluate intracellular lipid accumulation, cells were stained with Oil Red O as
described previously [26]. Briefly, after treating the cells, cells were washed three
times with iced PBS and fixed with 4 % paraformaldehyde. Fixed cells were washed
again with PBS and stained with Oil Red O solution (1.8 mg/mL Oil Red O in 60 %
ethanol) for 15 min at room temperature. After cells were washed again with PBS,
cells were observed on a phase contrast microscope (Olympus, Tokyo, Japan).
18.2.8 Cell Viability Assay
Cell viability was assessed by measuring a mitochondrial activity in reducing
2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazo-
lium monosodium salt (WST-8) to formazan using a Cell Counting Kit-8 (Dojindo,
Kumamoto, Japan) according to the manufacturer’s instructions. The amount of
formazan was quantified using a microplate reader (BioRad, Hercules, CA).
18.2.9 Annexin V-FITC/Propidium Iodide (PI) Staining
Palmitate-induced apoptosis of salivary gland cells was evaluated by an Annexin
V-FITC/PI staining with a TACS Annexin V-FITC Apoptosis Detection Kit (R and
D systems, Minneapolis, MN) according to the manufacturer’s instructions.
After treating the cells as described in the figure legends, fluorescent-positive
cells were detected by FACSVerse and analyzed by FACSuite (BD Biosciences,
San Diego, CA).
18.2.10 DAPI Staining
For detecting apoptosis in HSY cells, they were seeded on Lab-Tek chamber slides
(Nunc, Thermo Fisher Scientific, Rochester, NY). After treating the cells as
described in the figure legends, cells were washed three times with iced PBS and
fixed with 4 % paraformaldehyde followed by staining with 40,6-diamidino-2-
phenylindole (DAPI) (Invitrogen, Carlsbad, CA). Stained cells were visualized on
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a laser scanning confocal microscope (Carl Zeiss, Gottingen, Germany). Apoptotic
cells were morphologically defined as cells with nuclear shrinkage, condensation,
and fragmentation.
18.2.11 Data Analysis
To confirm the reproducibility of the results, all experiments were conducted at
least twice. Experimental values are given as mean standard deviation (SD). The
statistical significance of differences was evaluated using a Student’s unpaired t-test
or Dunnett’s multiple-comparison test after an analysis of variance (ANOVA) with
IBM SPSS Statistics software 19.0 (IBM, Armonk, NY). P values less than 0.05
were considered to be significant.
18.3 Results and Discussion
We obtained results as described below. (a) Palmitate treatment induces IL-6
secretion in HSY and HSG cells, but not HaCaT cells. (b) In salivary gland
epithelial cells, saturated fatty acids, but not unsaturated fatty acids, induces IL-6
secretion presumably through activation of NF-κB and p38 MAPK. (c) It has been
documented that lipotoxicity causes apoptosis, which is featured by some morpho-
logical changes such as cell shrinkage, cell rounding, and lipid accumulation [8,
27]. Thus, we investigated whether or not palmitate treatment induces morpholog-
ical changes. Palmitate treatment induced morphological changes which are cell
rounding and lipid accumulation in HSY and HSG cells. On the other hand, HSC-2
and HaCaT cells failed to accumulate lipid droplet after palmitate treatment despite
their tendency to round up (Fig. 18.1). (d) Palmitate treatment increases apoptosis
of HGY and HSG cells. (e) Palmitate induces a-fodrin degradation and caspase-3
activation in salivary gland epithelial cells. Details were already shown in our
report [28]. Moreover, we recently confirmed that, when model mice of primary
SS were fed with high-fat diet to elevate the serum level of saturated fatty acids,
their salivary glands and lacrimal glands exhibited inflammation significantly more
advanced than those observed in model mice fed with normal diet (data not shown).
Taken together, these results suggest that higher levels of saturated fatty acids may
promote the severity of primary SS.
In conclusion, our data indicate that palmitate may exacerbate the pathogenesis
of primary SS. Results presented in this report should encourage further investiga-
tions on relationship between metabolic-related disorders and autoimmune diseases
such as primary SS.
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